A single-center, open-label, randomized controlled trial for mycobacterial phage cocktail strategy for the treatment of superficial lymph node tuberculosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036343

Enrollment

Unknown

Registered

2020-08-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tuberculosis

Interventions

a:Mycobacteriophage

b:INH

c:Saline

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent 2. Patients with tuberculosis of lymph nodes confirmed by biopsy pathology or etiology; 3. Aged 18 to 65 years; 4. Patients who have a fixed address and phone number and can follow up.

Exclusion criteria

Exclusion criteria: 1. Allergic to phage preparations (skin test required) 2. Pregnant or lactating women 3. Patients with severe primary disease or severe heart, lung, liver, kidney and other major organ dysfunction

Design outcomes

Primary

Measure	Time frame
Lymph node size changes and skin healing time;	—

Countries

China

Contacts

Public ContactHuang Wei

Department of Tuberculosis, Shanghai Public Health Clinical Center

huangweiwin@yeah.net+86 15988678976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026